ELEBER

This brand name is authorized in Estonia, Croatia, Lithuania, Poland, Romania

Active ingredients

The drug ELEBER contains one active pharmaceutical ingredient (API):

1 Cabazitaxel UNII 51F690397J - CABAZITAXEL

Cabazitaxel is an antineoplastic agent that acts by disrupting the microtubular network in cells. Cabazitaxel binds to tubulin and promotes the assembly of tubulin into microtubules while simultaneously inhibiting their disassembly. Read about Cabazitaxel

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01CD04	Cabazitaxel	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01C Plant alkaloids and other natural products → L01CD Taxanes
Discover more medicines within L01CD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1813856
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-561829137
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1092637
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100433084
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67781001